These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2112164)

  • 1. The clinical development of mupirocin.
    Pappa KA
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
    Parenti MA; Hatfield SM; Leyden JJ
    Clin Pharm; 1987 Oct; 6(10):761-70. PubMed ID: 3146455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
    Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mupirocin: a new topical antibiotic.
    Leyden JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
    Breneman DL
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
    Rode H; de Wet PM; Millar AJ; Cywes S
    J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical antibiotic treatment of impetigo with mupirocin.
    Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
    Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Campoli-Richards DM
    Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retapamulin: a newer topical antibiotic.
    Dhingra D; Parakh A; Ramachandran S
    J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
    Bork K; Brauers J; Kresken M
    Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mupirocin: a new topical therapy for impetigo.
    Putnam CD; Reynolds MS
    J Pediatr Health Care; 1989; 3(4):224-7. PubMed ID: 2502615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    White DG; Collins PO; Rowsell RB
    J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Emulgel Delivery of Mupirocin for Treatment of Skin Infection.
    Jagdale SC; Kothekar PV
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):137-156. PubMed ID: 32814540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the role of mupirocin.
    Lamb YJ
    J Hosp Infect; 1991 Sep; 19 Suppl B():27-30. PubMed ID: 1684188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
    Odom RB
    Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.